The current price of CL is $98.69 — it has decreased by 0.07% since the previous close. Data as of Nov 5, 2026.
CL is up 0.70% over the past week, up 13.11% over the past month and up 27.72% over the past year. The price is above its 200-day moving average of $89.87.
Analysts' average 12-month price target for CL is $101.00, which implies 2.34% upside from the current price. Individual estimates range from $95.00 to $112.00.
Of the 21 analysts covering Colgate-Palmolive Company, 6 rate it a strong buy, 7 rate it a buy, 7 rate it a hold and 1 rates it a strong sell. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Colgate-Palmolive Company has a market capitalization of $78.45B. The company belongs to the Consumer Defensive sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Colgate-Palmolive Company posted earnings of $0.97 per share against an estimate of $0.926, beating expectations by 4.75%. Upcoming reports are listed in the earnings calendar.
Colgate-Palmolive Company reported revenue of $5.37B in its most recent quarter, which has increased by 4.64% compared with the same quarter a year earlier. Analysts had expected $5.34B.
Yes. Colgate-Palmolive Company pays dividends quarterly. The latest payment of $0.53 per share has a payment date of Nov 13, 2026, which corresponds to a dividend yield of 2.23%.
Companies most comparable to Colgate-Palmolive Company include The Procter & Gamble Company, Unilever PLC, Reckitt Benckiser Group plc, Henkel AG & Co. KGaA and Kenvue Inc.
In the latest trading session CL moved between $98.45 and $101.17, a range of 2.76% of its current price.
Over the past 52 weeks CL has traded between $75.96 and $101.17. The current price is 2.45% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.